Women's Health News
In the face of a multipronged front to drive blood pressure up, including a high-salt diet, females are better able to keep their pressure down by increasing levels of a T cell that selectively dials back inflammation, scientists say. Females have an innate ability to upregulate these anti-inflammatory cells, called Tregs, in response to a challenge, says Dr. Jennifer C. Sullivan, pharmacologist and physiologist, noting that the cell's levels are known to increase to help maintain a healthy pregnancy, for example, so the
immune system does not attack the fetus, which has DNA from both parents. "This is just a different challenge, but we are using those same protective pathways to do something else good for us," says Sullivan, professor in the Department of
Physiology at the Medical College of Georgia at Augusta University, who studies sex differences in hypertension, the so-called 'silent killer" that is a key risk factor for heart disease and stroke. Tregs are known to help protect us from an excessive immune response, like the cytokine storms causing so much destruction in COVID-19, as well as
autoimmune diseases like rheumatoid arthritis, where our
immune system attacks our own tissues, and are naturally associated with lower blood pressures and less organ damage.
High Impact List of Articles
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis,Hong Vu, Andrew E Mulberg
: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis,Hong Vu, Andrew E Mulberg
: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical